STUDY OBJECTIVES: To assess the resolution of @entity456 in @entity1 with @entity3254 ( @entity3254 ) during and after antituberculosis medication. DESIGN: An observational, prospective, longitudinal study. SETTING: University-affiliated general hospital in Seoul, Korea. @entity1 AND METHODS: Chest radiographs of 85 adult @entity3254 @entity1 were followed up prospectively from diagnosis to 24 months after the start of medication. The extent of @entity456 , synonymous with the radiographic term, @entity231 ( @entity231 ), was evaluated at regular intervals according to a size scale. Additionally, following completion of 6 months of therapy, residual @entity231 (RPO) was determined by either measurement of the widest width of the opacity, if loculated, or at the superior level of the hemidiaphragm. RESULTS: Seventy-seven @entity1 had a @entity231 graded > or = 2 at the initial presentation. At 6, 9, and 24 months, the number of @entity1 with these grades declined. At these time periods, there were 14, 8, and 7 @entity1 , respectively, remaining with this classification. RPO > 10 mm at 24 months was considered indicative of significant residual @entity456 . During the period after 6 months of antituberculosis medication, the number of @entity1 with RPO > or = 10 mm declined from 43 @entity1 at 6 months to 21 @entity1 at 24 months. The presence of loculation on an initial chest decubitus view was associated with significant RPO at 24 months (p = 0.009). CONCLUSION: In @entity3254 @entity1 , improvement of RPO often occurred even after completion of 6 months of antituberculosis medication up to 24 months. A loculated @entity231 at initial presentation, but not initial @entity231 size, was a predictor of significant RPO at 24 months.

Resolution of residual @entity456 according to time course in XXXX during and after the termination of antituberculosis medication.

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity3254 :: ('MESH:D014396', 'Disease') :: ['tuberculous pleurisy', 'TP'] @entity231 :: ('MESH:D002386', 'Disease') :: ['pleural opacity', 'PO'] @entity456 :: ('MESH:D010995', 'Disease') :: ['pleural disease']
@entity3254 :: (MESH:D014396,Disease) :: ['tuberculous pleurisy']
